OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producingEscherichia coli-Reference-Cited by-同舟云学术

OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producingEscherichia coli

Author:

Livermore David M¹²,Day Michaela¹,Cleary Paul³,Hopkins Katie L¹,Toleman Mark A⁴,Wareham David W⁵,Wiuff Camilla⁶,Doumith Michel¹,Woodford Neil¹

Affiliation:

1. Antimicrobial Resistance and Healthcare-Associated Infections Reference Unit, PHE National Infection Service, London, UK

2. Norwich Medical School, University of East Anglia, Norwich, UK

3. PHE Field Service, Liverpool, UK

4. Cardiff University, Heath Park Campus, Cardiff, UK

5. Blizard Institute, Queen Mary University of London, London, UK

6. Health Protection Scotland, Glasgow, UK

Funder

NIHR Policy Research Programme

Defining Reservoirs of ESBL-Producing E. coli

Threat Posed to Personal, Animal and Public Health

Independent Research

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

Reference37 articles.

2. Point-counterpoint: piperacillin-tazobactam should be used to treat infections with ESBL-positive organisms;Schuetz;J Clin Microbiol,2018

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献